A fully human antibody neutralising biologically active human TGFbeta2 for use in therapy.
Thompson JE, Vaughan TJ, Williams AJ, Wilton J, Johnson KS, Bacon L, Green JA, Field R, Ruddock S, Martins M, Pope AR, Tempest PR, Jackson RH.
Thompson JE, et al. Among authors: tempest pr.
J Immunol Methods. 1999 Jul 30;227(1-2):17-29. doi: 10.1016/s0022-1759(99)00060-5.
J Immunol Methods. 1999.
PMID: 10485251